Nomad Power Solutions (NMAD) widens loss as cash rises and merger reshapes company
Nomad Power Solutions (formerly Lixte Biotechnology) reported a widened net loss of $2.34 million in Q2 2026 and $4.33 million for the first half of 2026, primarily due to increased general and administrative and research and development expenses. Despite the losses, the company's cash …